Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Chromatogr ; 31(1)2017 Jan.
Article in English | MEDLINE | ID: mdl-27511598

ABSTRACT

Histone deacetylase inhibitors (HDAC inhibitors) are used to treat malignancies such as cutaneous T cell lymphoma and peripheral T cell lymphoma. Only four drugs are approved by the US Food and Drug Administration, namely vorinostat, romidepsin, panobinostat and belinostat, while chidamide has been approved in China. There are a number of bioanalytical methods reported for the measurement of HDAC inhibitors in clinical (human plasma and serum) and preclinical (mouse plasma, rat plasma, urine and tissue homogenates, etc.) studies. This review covers various HDAC inhibitors such as vorinostat, romidepsin, panobinostat, belinostat and chidamide. In addition to providing a comprehensive review of the available methods for the above mentioned HDAC inhibitors, it also provides case studies with perspectives for chosen drugs. Based on the review, it is concluded that the published methodologies using either HPLC or LC-MS/MS are well suited for the quantification of HDAC inhibitors in various biological fluids to delineate pharmacokinetic data.


Subject(s)
Chromatography, High Pressure Liquid/methods , Histone Deacetylase Inhibitors/pharmacokinetics , Tandem Mass Spectrometry/methods , Aminopyridines/blood , Aminopyridines/pharmacokinetics , Aminopyridines/urine , Animals , Benzamides/blood , Benzamides/pharmacokinetics , Benzamides/urine , Depsipeptides/blood , Depsipeptides/pharmacokinetics , Depsipeptides/urine , Histone Deacetylase Inhibitors/blood , Histone Deacetylase Inhibitors/urine , Humans , Hydroxamic Acids/blood , Hydroxamic Acids/pharmacokinetics , Hydroxamic Acids/urine , Indoles/blood , Indoles/pharmacokinetics , Indoles/urine , Neoplasms/drug therapy , Panobinostat , Sulfonamides/blood , Sulfonamides/pharmacokinetics , Sulfonamides/urine , Vorinostat
2.
Drug Res (Stuttg) ; 66(7): 351-6, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27120083

ABSTRACT

Bendamustine is an alkylating agent administered as 1 h intravenous infusion in the clinic for the treatment of malignant haematological cancers. The aim of the study was to evaluate the pharmacokinetics of bendamustine and its key cytochrome P 450 (CYP) 1A2 mediated γ-hydroxybendamustine (M3) metabolite after 30- and 60-min intravenous infusion of bendamustine in rats. 2 groups were assigned to receive bendamustine either as 30- or 60-min infusion and doses were normalized to 15 mg/kg for the sake of statistical evaluation. Serial pharmacokinetic samples were collected and were analysed for the circulatory levels of bendamustine and its M3 metabolite. Standard pharmacokinetic parameters were generated for bendamustine and its M3 metabolite. Regardless of the intravenous regimens, Cmax coincided with end of infusion for both bendamustine and its M3 metabolite. Immediately after stoppage of infusion, a rapid decline in the plasma levels occurred for both bendamustine and M3 metabolite. The Cmax and AUC0-∞ parameters for bendamustine after 60-min infusion were 1.90 and 1.34-fold higher; while CL was lower by 1.32-fold as compared to the 30-min infusion. In contrast, the Cmax and AUC0-∞ after 30-min infusion for the M3 metabolite was 2.15- and 2.78-fold greater; while CL was 2.32-fold lower when compared to the 60-min infusion. However, T1/2 and Vz values were similar between the 2 intravenous treatments for bendamustine or the M3 metabolite. The data unequivocally confirmed the existence of differential pharmacokinetics of bendamustine and its M3 metabolite as the function of the duration of intravenous infusion.


Subject(s)
Bendamustine Hydrochloride/analogs & derivatives , Bendamustine Hydrochloride/administration & dosage , Bendamustine Hydrochloride/pharmacokinetics , Animals , Bendamustine Hydrochloride/blood , Bendamustine Hydrochloride/metabolism , Infusions, Intravenous , Male , Rats , Time Factors
3.
Biomed Chromatogr ; 30(7): 1138-1144, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26633099

ABSTRACT

A highly sensitive, specific and rapid LC-ESI-MS/MS method has been developed and validated for the quantification of rocilinostat in small volume mouse plasma (20 µL) using vorinostat as an internal standard (IS) as per regulatory guidelines. Sample preparation was accomplished through a protein precipitation procedure with acetonitrile. Chromatography was achieved on Prodigy ODS-2 column using a binary gradient using mobile phase A (0.2% formic acid in water) and B (acetonitrile) at a flow rate of 0.38 mL/min. The total chromatographic run time was 4.1 min and the elution of rocilinostat and IS occurred at ~3.2 and 2.9 min, respectively. A linear response function was established in the concentration range of 0.28-1193 ng/mL in mouse plasma. The intra- and inter-day accuracy and precisions were in the ranges of 3.12-8.93 and 6.41-11.6%, respectively. This novel method has been applied to a pharmacokinetic study in mice. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Chromatography, Liquid/methods , Hydroxamic Acids/blood , Pyrimidines/blood , Tandem Mass Spectrometry/methods , Animals , Limit of Detection , Male , Mice , Mice, Inbred BALB C
4.
Lipids ; 49(3): 225-33, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24338560

ABSTRACT

In the present study we evaluated the uptake of ALA and its conversion to EPA + DHA in rats given linseed oil (LSO) in native form or as a microemulsion in whey protein or in lipoid. In a single oral dose study in which rats maintained on rodent pellets deficient in ω-3 fatty acids were intubated with 0.35 g LSO in lipoid, the amount of ALA present in lymph was increased reaching a maximum concentration of 16.23 mg/ml at 2.5 h. The amount of ALA present in lymph was increased to a maximum level of 10.95 mg/ml at 4 h in rats given LSO as a microemulsion in whey protein. When LSO was given without emulsification, the amount of ALA present in lymph was found to reach a maximum level of 7.08 mg/ml at 6 h. A similar result was observed when weaning rats were intubated with 0.15 g of LSO per day for a period of 60 days. Higher levels of ALA by 41 and 103 % were observed in lymph lipids of rats given microemulsions of LSO in whey protein and in lipoid respectively as compared to rats given LSO without pre-emulsification. Very little conversion of ALA to EPA and DHA was observed in lymph lipids but higher amounts of EPA + DHA was observed in liver and serum of rats given LSO in microemulsion form. This study indicated that ALA concentration in lymph lipids was increased when LSO was given in microemulsion form in lipoid and further conversion to EPA and DHA was facilitated in liver and serum.


Subject(s)
Animal Feed , Fatty Acids, Omega-3/biosynthesis , Linseed Oil/administration & dosage , Lymphatic System/metabolism , alpha-Linolenic Acid/pharmacokinetics , Animals , Emulsions , Male , Rats , Rats, Wistar , alpha-Linolenic Acid/metabolism
5.
Chin J Nat Med ; 11(2): 145-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23787181

ABSTRACT

AIM: The present study was aimed at evaluating the antiulcer activity of the polyherbal formulation (PHF) containing the leaf extracts of Moringa oleifera, Raphinus sativus, and Amaranthus tricolor in rats. METHODS: The antiulcer activity of the polyherbal formulation (PHF) was evaluated using different models of gastric ulcers: ethanol-induced, indomethacin-induced and ischemia reperfusion-induced gastric ulcers. Efficacy was assessed by determining the ulcer index. RESULTS: Administration of the polyherbal formulation (150 mg·kg(-1), p.o.) offered significant protection against indomethacin-induced, ethanol-induced, and ischemic reperfusion-induced ulcer models when compared to the control group. CONCLUSION: PHF, containing leaf extracts of Moringa oleifera, Raphinus sativus, and Amaranthus tricolor, was found to possess antiulcer properties in three experimental animal models of gastric ulcers, and these findings suggest that the significant gastroprotective activity could be mediated by its antioxidant activity.


Subject(s)
Amaranthus/chemistry , Anti-Ulcer Agents/administration & dosage , Brassicaceae/chemistry , Moringa oleifera/chemistry , Plant Extracts/administration & dosage , Stomach Ulcer/drug therapy , Animals , Chemistry, Pharmaceutical , Humans , India , Male , Phytotherapy , Plant Leaves/chemistry , Plants, Medicinal/chemistry , Rats, Wistar , Stomach Ulcer/prevention & control
6.
Biomed Chromatogr ; 26(12): 1464-71, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22354844

ABSTRACT

A highly sensitive, rapid assay method has been developed and validated for the estimation of nobiletin in rat plasma with liquid chromatography coupled to tandem mass spectrometry with electrospray ionization in the positive-ion mode. The assay procedure involves extraction of nobiletin and citalopram (internal standard, IS) from rat plasma with liquid-liquid extraction. Chromatographic separation was achieved using an isocratic mobile phase (0.2% formic acid-acetonitrile, 20:80, v/v) at a flow rate of 0.6 mL/min on an Atlantis dC18 column (maintained at 40 ± 1 °C) with a total run time of 2.0 min. The MS/MS ion transitions monitored were 403.2 → 373.0 for nobiletin and 325.2 → 109.0 for IS. Method validation was performed as per Food and Drug Administration guidelines and the results met the acceptance criteria. The lower limit of quantitation achieved was 0.05 ng/mL and the linearity range extended from 0.05 to 51.98 ng/mL. The intra- and inter-day precisions were in the range of 1.96-14.3 and 6.21-12.1, respectively.


Subject(s)
Chromatography, High Pressure Liquid/methods , Flavones/blood , Spectrometry, Mass, Electrospray Ionization/methods , Tandem Mass Spectrometry/methods , Acetonitriles/chemistry , Animals , Calibration , Drug Stability , Flavones/chemistry , Flavones/pharmacokinetics , Formates/chemistry , Linear Models , Liquid-Liquid Extraction , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sensitivity and Specificity
7.
Asian Pac J Trop Biomed ; 1(2): 142-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-23569745

ABSTRACT

OBJECTIVE: To evaluate the hepatoprotective potential of Hepax, a polyherbal formulation, against three experimentally induced hepatotoxicity models in rats. METHODS: Hepatoprotective activity of Hepax was studied against three experimentally induced hepatotoxicity models, namely, carbon tetrachloride (CCl4), paracetamol and thiocetamide induced hepatotoxicity in rats. RESULTS: Administration of hepatotoxins (CCl4, paracetamol and thiocetamide) showed significant morphological, biochemical and histological deteriorations in the liver of experimental animals. Pretreatment with Hepax had significant protection against hepatic damage by maintaining the morphological parameters (liver weight and liver weight to organ weight ratio) within normal range and normalizing the elevated levels of biochemical parameters (SGPT, SGOT, ALP and total bilirubin), which were evidently showed in histopathological study. CONCLUSIONS: The Hepax has highly significant hepatoprotective effect at 100 and 200 mg/kg, p.o. on the liver of all the three experimental animal models.


Subject(s)
Chemical and Drug Induced Liver Injury/prevention & control , Plant Extracts/administration & dosage , Plants, Medicinal/chemistry , Protective Agents/administration & dosage , Acetaminophen/adverse effects , Animals , Carbon Tetrachloride/adverse effects , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/pathology , Female , Humans , India , Liver/drug effects , Liver/pathology , Male , Phytotherapy , Rats , Rats, Wistar
8.
Saudi Pharm J ; 19(3): 171-6, 2011 Jul.
Article in English | MEDLINE | ID: mdl-23960756

ABSTRACT

Raphinus sativus Linn (Cruciferae) commonly known as 'Radish' is a multipurpose herb cultivated in different parts of the world for its edible roots and leaves. The present study was aimed to evaluate the antiulcer activity of leaf extracts of R. sativus Linn on acetic acid induced chronic gastric ulcer and pylorus ligation induced gastric ulcer in rats. The acute oral toxicity study revealed that all the extracts were safe up to 2000 mg/kg per oral dose; hence one-tenth of this dose was selected for evaluation of antiulcer activity. In acetic acid induced gastric ulcer models, the ERS, CRS, EARS and AQRS have offered significant protection against acetic acid induced ulcers when compared to control group. While in pylorus ligation induced ulcer model the ERS, EARS and AQRS showed significant protection by decreasing the ulcer index, total acidity and free acidity. In conclusion the leaf extracts of R. sativus Linn are found to possess antiulcer property in the experimental animal models of gastric ulcers, which is consistent with the literature report in the folk medicine.

SELECTION OF CITATIONS
SEARCH DETAIL
...